{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T15:02:55Z","timestamp":1789311775691,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.eprac.2022.03.013","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T21:33:58Z","timestamp":1648071238000},"page":"572-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The Prolactin per Unit Tumor Volume Ratio Accurately Distinguishes Prolactinomas From Secondary Hyperprolactinemia due to Stalk Effect"],"prefix":"10.1016","volume":"28","author":[{"given":"Alexander","family":"Faje","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Swearingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Tritos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.eprac.2022.03.013_bib1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2265.1996.8210831.x","article-title":"Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia","volume":"45","author":"Beentjes","year":"1996","journal-title":"Clin Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2022.03.013_bib2","first-page":"508","article-title":"Serum prolactin concentration at presentation of non-functioning pituitary macroadenomas","volume":"36","author":"Behan","year":"2013","journal-title":"J\u00a0Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.eprac.2022.03.013_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00701-012-1285-5","article-title":"Intraoperative MRI and endocrinological outcome of transsphenoidal surgery for non-functioning pituitary adenoma","volume":"154","author":"Berkmann","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"issue":"3-A","key":"10.1016\/j.eprac.2022.03.013_bib4","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1590\/S0004-282X2002000400014","article-title":"[Influence of hyperprolactinemia and tumoral size in the postoperative pituitary function in clinically nonfunctioning pituitary macroadenomas]","volume":"60","author":"Fonseca","year":"2002","journal-title":"Arq Neuropsiquiatr"},{"issue":"4","key":"10.1016\/j.eprac.2022.03.013_bib5","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2265.2006.02627.x","article-title":"Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma","volume":"65","author":"Karavitaki","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.eprac.2022.03.013_bib6","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/1756-0500-7-555","article-title":"Diagnostic pitfalls of hyperprolactinemia: the importance of sequential pituitary imaging","volume":"7","author":"Kawaguchi","year":"2014","journal-title":"BMC Res Notes"},{"issue":"5","key":"10.1016\/j.eprac.2022.03.013_bib7","first-page":"653","article-title":"Detection of mRNA of prolactin and ACTH in clinically nonfunctioning pituitary adenomas","volume":"69","author":"Sakurai","year":"1988","journal-title":"J\u00a0Neurosurg"},{"issue":"2","key":"10.1016\/j.eprac.2022.03.013_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.2010-1692","article-title":"Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline","volume":"96","author":"Melmed","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2022.03.013_bib9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1210\/jc.2010-1048","article-title":"Pituitary incidentaloma: an endocrine society clinical practice guideline","volume":"96","author":"Freda","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2022.03.013_bib10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.eprac.2022.03.013_bib11","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12020-015-0791-7","article-title":"Giant prolactinomas: are they really different from ordinary macroprolactinomas?","volume":"52","author":"Espinosa","year":"2016","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.eprac.2022.03.013_bib12","first-page":"834","article-title":"Magnetic resonance imaging measurements of pituitary stalk compression and deviation in patients with nonprolactin-secreting intrasellar and parasellar tumors: lack of correlation with serum prolactin levels","volume":"34","author":"Smith","year":"1994","journal-title":"Neurosurgery"},{"issue":"3","key":"10.1016\/j.eprac.2022.03.013_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/EJE-19-0238","article-title":"Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis","volume":"181","author":"Faje","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"10.1016\/j.eprac.2022.03.013_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.eprac.2022.03.013_bib15","first-page":"2010","article-title":"Role of prolactin\/adenoma maximum diameter and prolactin\/adenoma volume in the differential diagnosis of prolactinomas and other types of pituitary adenomas","volume":"15","author":"Huang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.eprac.2022.03.013_bib16","first-page":"1","article-title":"Prolactinomas and nonfunctioning adenomas: preoperative diagnosis of tumor type using serum prolactin and tumor size","author":"Burke","year":"2019","journal-title":"J\u00a0Neurosurg"},{"issue":"1","key":"10.1016\/j.eprac.2022.03.013_bib17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12020-021-02744-8","article-title":"Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas","volume":"74","author":"Wright","year":"2021","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.eprac.2022.03.013_bib18","doi-asserted-by":"crossref","first-page":"9801","DOI":"10.1038\/s41598-021-89256-7","article-title":"Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis","volume":"11","author":"Leca","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.eprac.2022.03.013_bib19","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1677\/ERC-08-0181","article-title":"Medical therapy for clinically non-functioning pituitary adenomas","volume":"15","author":"Colao","year":"2008","journal-title":"Endocr Relat Cancer"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22000994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X22000994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:12:07Z","timestamp":1761516727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X22000994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1530891X22000994"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2022.03.013","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Prolactin per Unit Tumor Volume Ratio Accurately Distinguishes Prolactinomas From Secondary Hyperprolactinemia due to Stalk Effect","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2022.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AACE. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}